The increasing age and deteriorating health of Americans, an expected shortage of cardiologists in the future, and the shift of cardiac procedures to outpatient settings have led to increased transaction activity in cardiology practices in recent years. Cardiology groups are in a position to benefit whether they enter into a deal with a private equity-backed PPM or a health system.
This HealthCare Appraisers article discusses the key drivers to transaction activity in the cardiology sector, provides insight into the current transaction environment, and outlines the value propositions that different buyers bring to a transaction. Read more.
Related Posts
Flare Capital Partners Raises $350M Healthcare Fund
The fund is focused on healthcare technology companies.
April 29, 2022
Exploring Private Equity’s Role in Behavioral Health Care
In recent years, they’ve been attracted by skyrocketing demand for services following the COVID-19 pandemic and the opportunity to consolidate a fragmented industry.
November 23, 2022
Abrupt Closure of Compass Medical Sends Shockwaves Through Struggling Mass. Healthcare System
Compass Medical, which has 80 physicians and serves 70,000 patients, said earlier this week that it would close its practices, effective immediately.
June 2, 2023
Home Health Consolidators Juggle Build-Versus-Buy Strategies in Increasingly Competitive Market
After multiple years of record-breaking M&A activity, home health consolidators are now starting to show an increased interest in organic growth.
June 7, 2022